NEW YORK (GenomeWeb News) – Next-generation sequencing-based cancer testing firm OncoDNA has been chosen by the National Blood and Cancer Center in Saudi Arabia as a preferred supplier of molecular diagnostic tests to parts of the Middle East.

Under the terms of the agreement, OncoDNA will make available its OncoDEEP DX and OncoDEEP Clinical cancer panels to Gulf Cooperation Council countries, comprising Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.